Related Experiment Videos
The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty
M Capanni1, D Prisco, E Antonucci
1Istituto di Clinica Medica Generale e Cardiologia, University of Florence, Italy.
Insights
Percutaneous transluminal coronary angioplasty increases platelet aggregation post-procedure. Pre-existing platelet function significantly impacts clinical recurrence risk after coronary angioplasty.
Area of Science:
- Cardiology
- Hematology
- Interventional Cardiology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common treatment for coronary artery disease.
- Despite its efficacy, restenosis remains a significant complication, occurring in 25-40% of cases.
- The impact of PTCA on platelet function and its correlation with clinical outcomes require further investigation.
Purpose of the Study:
- To evaluate the immediate effects of PTCA on platelet aggregation.
- To determine the relationship between pre-procedural platelet function and clinical recurrence after PTCA.
Main Methods:
- Assessed spontaneous platelet aggregation in platelet-rich plasma before and after successful PTCA in 155 patients.
- Followed patients for a mean of 20 months, with angiography for clinically recurrent cases.
- Utilized Kaplan-Meier analysis to assess event-free survival based on baseline platelet aggregation.
Main Results:
- A significant increase in spontaneous platelet aggregation was observed in 79% of patients immediately post-PTCA.
- Patients who experienced clinical recurrence had significantly lower baseline spontaneous platelet aggregation (P<0.05).
- A relative risk of 2.5 for clinical recurrence was noted in patients with the lowest quintile of baseline platelet aggregation (P<0.05).
Conclusions:
- PTCA acutely enhances spontaneous platelet aggregation.
- Pre-procedural platelet function is a critical determinant of clinical recurrence risk following PTCA.
- Assessing platelet function before PTCA may aid in stratifying patient risk for adverse events.
Abstract:
Percutaneous transluminal coronary angioplasty is an established therapy for coronary artery disease, but restenosis still occurs at a rate of 25%-40%. The aim of this study was to investigate the acute effect of percutaneous transluminal coronary angioplasty on platelet function and the relationship between platelet function and clinical recurrence. Spontaneous platelet aggregation was assessed before and after successful coronary angioplasty in 155 patients (120 men, 35 women). Patients were followed for a mean time of 20 months; follow-up angiography was performed only in patients with clinical recurrence. In 122 of 155 patients (79%) a significant increase in spontaneous platelet aggregation was observed immediately after coronary angioplasty. Baseline spontaneous platelet aggregation in platelet-rich plasma was significantly lower in patients with clinical recurrence than in those without (P<0.05). Kaplan-Meier event-free survival estimate showed a significant difference in clinical recurrence between patients with spontaneous platelet aggregation in platelet-rich plasma below and above the first quintile (P<0.05) with a relative risk of 2.5. In conclusion. these results indicate that percutaneous transluminal coronary angioplasty enhances spontaneous platelet aggregation and that the platelet state before coronary angioplasty affects the risk of clinical recurrence after the procedure.